Robert P. Lenk, Director at PLUS THERAPEUTICS, INC. (PSTV), bought 7,395 shares at $1.64 ($12K) on 2023-11-07, disclosed to the SEC on 2023-11-08.
Open-market purchase of $12k PSTV by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.50 | 1,395 | $2K | 17.5% |
| 2 | $1.64 | 6,000 | $10K | 82.5% |
| Total | $1.61 avg | 7,395 | $12K | 100% |
| Filing → |
| PSTV | BUY | 2023-11-17 | $4K | — | Filing → |
| PSTV | BUY | 2023-11-15 | $9K | — | Filing → |
| PSTV | BUY | 2023-11-13 | $15K | — | Filing → |